Forskarstuderande vid enheten för kirurgi och onkologiRegistrerade doktorander Ebba AsplundLiquid biopsy before and after surgery for pancreatic cancerE-post: ebba.asplund@ki.se Ruth BaumgartnerClinical and tumour biological aspects of patients undergoing hepatectomy for primary and srcondary liver tumoursE-post: ruth.baumgartner@ki.seErik BergquistPancreatic cancer – early diagnostics and surgical treatment of premalignant lesionsE-post: erik.bergquist@ki.sePeter ElbeDoktorandE-post: peter.elbe@ki.seAngeline Enton RajOutcomes of multimodality treatment of esophageal adenocarcinoma based on immunological subtypesE-post: angeline.enton.raj@ki.seTruls GråbergDoktorandE-post: truls.graberg@ki.se Beate GündelInvestigation of pancreatic cancer aided by 3D-culture modelsE-post: beate.gundel@ki.seAnders HolménNutrition and health-related quality of life after multimodality treatment of gastroesophageal cancerE-post: anders.holmen@ki.seBiying HuangPeritoneal disease in gastric cancerE-post: biying.huang@ki.seStudies on bile leakage after hepatic resectionMagnus KonradssonGastric outlet obstruction after esophagectomy: Epidemiology , diagnosis and treatmentE-post: magnus.konradsson@ki.se Patrik LarssonThe impact of heart disease on patients with malignant and premalignant pancreatic diseasesE-post: patrik.larsson@ki.seHenrik MaltzmanOptimizing outcomes for gastroesophageal cancer in the era of endoscopic treatmentE-post: henrik.maltzman@ki.seAnn MorgellPreemptive pancreatic surgeryE-post: ann.morgell@ki.seKlara NilssonAspects of the timing of surgical resection after neoadjuvant chemoradiotherapy in treatment of esophageal cancerE-post: klara.nilsson@ki.seNora NorénMolecular subtypes, therapeutic approach and outcome in gastroesophageal cancerE-post: nora.noren@ki.seMarcus NömmCognitive impact associated with surgery for gastric and esophageal cancerE-post: marcus.nomm@ki.se Halla Sif ÓlafsdóttirRadiotherapy in the Treatment of Oesophageal CancerE-post: halla.sif.olafsdottir@ki.se Dawid RutkowskiA deep learning-based radiogenomic approach to assess tumour characteristics in pancreatic cancerE-post: dawid.rutkowski@ki.seWiktor RutkowskiTumor-related fecal dysbiosis in pancreatic cancer patientE-post: wiktor.rutkowski@ki.seGabriel SalibaThe role of molecular subtypes and biomarkers in gastroesophageal adenocarcinoma for individually tailored treatment and increased overall survivalE-post: gabriel.saliba@ki.seCaroline SalménTumor-biology of liver metastases: Clinical and clinicopathological studiesE-post: caroline.salmen@ki.seJohanna Samola WinnbergHereditary ventricular cancerE-post: johanna.samola.winnberg@ki.seDaniel SelinAspects of acute pancreatitis – studies on etiology and outcomeE-post: daniel.selin@ki.se Sara SöderqvistReplacement Growth in Pancreatic Cancer and its Liver Metastases: Live Cell Studies and Clinical ConnectionsE-post: sara.soderqvist@ki.seJohn ThörlingAspects of glucose metabolism in acute surgical and orthopedic patientsE-post: john.thorling@ki.se Annika ViljamaaLiver Metastases Encapsulation: Cellular Players and Molecular MechanismsE-post: annika.viljamaa@ki.seLinn Christina WestinInguinal hernia - optimizing surgical treatment.E-post: linn.westin@ki.seHannes WållgrenRobotic-assisted contra open resection for suspected or confirmed gallbladder cancerE-post: hannes.wallgren@ki.se
